Bioorganic & Medicinal Chemistry · 2013 · 66 citations · 30 references
MedicineMedicinal ChemistryOncologyCancer PharmacologyStructure-activity RelationshipsSynthetic Medicinal ChemistryLead Compound DesignOncology PharmacologyPharmacodynamics Of Anticancer AgentsPharmacodynamics Of Anticancer DrugsStructure-activity Relationship AnalysisAnticancer ActivityAnticancer ChemotherapyAnticancer Mechanism Of ActionSpirocyclic Scaffolds
30
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations
Medicine, Oncology, Pharmacology +15
Requirement for p53 and p21 to Sustain G <sub>2</sub> Arrest After DNA Damage
Fred Bunz, Annie Dutriaux, Christoph Lengauer et al. · Science · 1998 · 2.8K citations
Structure-Based Design of Potent Non-Peptide MDM2 Inhibitors
Ke Ding, Yipin Lu, Zaneta Nikolovska‐Coleska et al. · Journal of the American Chemical Society · 2005 · 649 citations
Li Sun, Ngoc Quang Tran, Flora Tang et al. · Journal of Medicinal Chemistry · 1998 · 488 citations · Full text